Pasithea Therapeutics Warrants
KTTAW
6 hedge funds and large institutions have $3.18K invested in Pasithea Therapeutics Warrants in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
20% more funds holding
Funds holding: 5 → 6 (+1)
42% less capital invested
Capital invested by funds: $5.52K → $3.18K (-$2.34K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$170 |
| 2 |
TSS
Two Sigma Securities
New York
|
+$13 |
| 3 |
CS
Clear Street
New York
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$150 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $2K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $397 | +$13 | +1,895 | +3% |
|
|
AC
3
Armistice Capital
New York
| $345 | – | – | – |
|
|
MG
4
Marex Group
London,
| $223 | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $216 | +$170 | +24,293 | New |
|
|
CS
6
Clear Street
New York
| $3 | +$3 | +380 | New |
|
|
7
Osaic Holdings
Scottsdale,
Arizona
| – | -$150 | -15,000 | Closed |
|
KTTAW Hedge Fund Activity: Q2 2026 in Review
6 of the 8,279 institutional investors tracked by Wall St. Rank reported a position in Pasithea Therapeutics Warrants (KTTAW) for Q2 2026, worth a combined $3.18K — down 42% from $5.52K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KTTAW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $170. The largest seller was Osaic Holdings, exiting entirely with an estimated $150 sold.
- 6 institutional investors held Pasithea Therapeutics Warrants (KTTAW) as of Q2 2026, up from 5 in Q1 2026.
- Funds reported $3.18K of Pasithea Therapeutics Warrants stock for Q2 2026, down 42% quarter-over-quarter.
- 2 funds opened new Pasithea Therapeutics Warrants positions in Q2 2026 and 1 closed out, a net change of +1 holder.
- The largest Pasithea Therapeutics Warrants buyer in Q2 2026 was Susquehanna International Group, an estimated $170 added.
- The largest Pasithea Therapeutics Warrants seller in Q2 2026 was Osaic Holdings, an estimated $150 sold.
Based on aggregated 13F filings for Q2 2026.